Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|24|4|465-477

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.4, 2018-04, pp. : 465-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin may offer less survival benefit in patients with diabetes after acute coronary syndromes than in those without diabetes

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US

By Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 3, 2012-06 ,pp. : 207-216

Adis International

Access to resources Recommend Favorite

Prasugrel: A Review of its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

By Duggan Sean T.   Keating Gillian M.  

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1707-1726

Adis International

Access to resources Recommend Favorite

Prasugrel versus Clopidogrel Antiplatelet Therapy after Acute Coronary Syndrome: Matching Treatments with Patients

By Tcheng James E.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite

Clopidogrel: a CURE in acute coronary syndromes?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 351-353

Informa Healthcare

Access to resources Recommend Favorite